The development of ovarian carcinosarcoma from serous tubal intraepithelial carcinoma: an immunohistochemical case report with literature review
Ovarian carcinosarcoma (OCS) is an uncommon and highly aggressive subtype of ovarian carcinoma characterized by the simultaneous occurrence of two malignant components: carcinomatous and sarcomatous. Located at the fimbrial region of the fallopian tube, serous tubal intraepithelial carcinoma (STIC) represents a form of precursor lesion for high-grade serous carcinoma (HGSC). In the current report, we present an intriguing case study of left OCS concomitant with ipsilateral STIC. Immunohistochemical (IHC) assessment showed a similar staining pattern of the carcinomatous OCS component and STIC. In conclusion, the development of OCS from STIC should be considered. Such a situation represents both a rare phenomenon and a challenge for preoperative diagnostic protocol. A careful application of selected IHC markers, p53 and Ki-67 in particular, may substantially help not only in the differential diagnosis but also in clinicopathological algorithms based on OCS molecular profiling into HGSC-like and non-HGSC-like variants.
Authors
- Dorota Lewkowicz (ORCID: https://orcid.org/0000-0002-5512-8285)
- Andrzej Semczuk (ORCID: https://orcid.org/0000-0001-9344-9437)
- Maciej Jóźwik
- Paula Szlendak (ORCID: https://orcid.org/0000-0001-8880-3139)
- Marek Semczuk
- Andrea Romano
Institutions
- Gynecologic Oncology Group (US)
- Medical University of Lublin (PL)
- Maastricht University Medical Centre (NL)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-04-15
- DOI
- https://doi.org/10.3389/fonc.2026.1727634
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00